Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
about
The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic TestingBig data from small samples: Informatics of next-generation sequencing in cytopathology.The use of endobronchial ultrasound guided transbronchial needle aspiration specimens for next generation sequencing in non-small cell lung cancer: a clinical perspective.Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).Factors affecting the success of next-generation sequencing in cytology specimens.Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic seriesMolecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.EGFR analysis: current evidence and future directions.Biospecimen repositories and cytopathology.Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.Massively parallel DNA sequencing from routinely processed cytological smears.FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.Optimizing the DNA yield for molecular analysis from cytologic preparations.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology.Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumorsUsing "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.Challenges and opportunities for next-generation sequencing in companion diagnostics.Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples.Next-generation sequencing of cytologic preparations: An analysis of quality metrics.Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience.Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients.Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer.Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.Two decades of lung cancer through the pages of Cancer Cytopathology.Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing.[Cytological material for molecular pathology].
P2860
Q26824315-C7AD43B0-FABD-43AD-B370-376D672E3C72Q31146982-07DF5852-34DF-472F-AFE7-85BB7790C3A2Q33639153-8093C79F-69AD-4E52-9015-286CA8AB70E4Q35237841-C568CEFF-FAD2-4C1C-88C6-B7840C2DA180Q35662768-EB6C5ADB-5BA9-42F2-8680-C11E20A9A778Q35730088-9486E252-F34D-4EB7-80E2-F5C3ADFFCA25Q36135533-008852B4-57C8-4053-8F58-BEA57B9611CFQ36441399-EBF23B1D-A204-4A3F-9EA3-ED0710EDB417Q37193365-BAC092EA-AC55-4240-BA6F-07120ED6AA78Q37296060-4D7B3D5D-AAF1-4B63-82BB-3874F7D00452Q37317218-CA8044F0-66AF-47D1-8852-1680752432AEQ38195265-DE9058B3-E2CD-4280-B01A-5E9950AF6724Q38294129-7A265839-214A-4F0F-AF6E-84316BE148C3Q38352879-BA5B9254-44B8-4735-8B98-B374C93AE0B0Q38376363-D5CDC974-A33A-4826-BD83-CC6F808E0FECQ38383838-4DA689EE-2764-4402-B507-0197FBF65AC9Q38409652-91BA9E76-2AAB-4F6A-9D9C-3B0F33A31AAAQ38423398-FF889EA0-9A79-437B-95A5-61C3029130BCQ38591866-9EB61C91-3FE1-44AF-A4DC-BA1B6F296F4DQ38672934-420FFC64-AAF9-4775-9831-A9C4FE8A634CQ38814876-A2222FD3-08CA-4DF3-9832-AF1A7A005990Q38824891-F15DF5B5-FB2A-4D31-BCBC-0E92257B1259Q38921083-015F5A99-F841-4CAC-8064-C834E57489E8Q38937135-A8B0CA5B-D51A-46A4-99D9-00F7E7D824BDQ39255918-C860E414-5C25-455C-8551-0552A2342851Q40195925-49E7C60C-3F09-4E27-9DD3-D3AFD776EC94Q43891611-A163C3FB-D890-48F1-874D-367384DAFBF3Q46092645-57C603E7-0297-4531-98E8-5E473D31E43DQ47662044-F4AC6C9C-ABC2-4FA4-90F8-0CEFA179AFDBQ48094842-BE039B11-E601-4720-A6A7-FC37578B4C4EQ51662748-AF9D060D-3927-4E31-9ECE-D70E57B516CEQ52587597-28244F9A-24C5-4F3A-9E1A-F6096B15B1D4Q52904961-676BDBEE-D884-4FA2-BCA2-61F43D7B7D69Q52927134-3C8A14F7-B30D-44DE-9A31-2AE4ED0D4861Q53082169-DEB8AE38-8905-41B3-9841-70705391D5EFQ53534519-F6BD26BC-7B1C-42B4-88C6-A93DF47C6423Q53813026-9B3F341E-004E-47AF-82E3-6077A932935D
P2860
Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@en
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@nl
type
label
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@en
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@nl
prefLabel
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@en
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@nl
P2093
P2860
P356
P1433
P1476
Targeted next-generation seque ...... m adenocarcinomas of the lung.
@en
P2093
Cory T Bernadt
Eric J Duncavage
Hope E Karnes
P2860
P304
P356
10.1002/CNCY.21361
P577
2013-11-12T00:00:00Z